Omfiloctocog alfa

Omfiloctocog alfa (SCT-800) is a recombinant factor VIII (FVIII) . FVIII is an essential blood coagulation protein and a key component of the fluid phase blood coagulation system. Omfiloctocog alfa can be used for the research of Hemophilia A[1][2].

Product Specifications

CAS Number

[2249927-58-8]

Product Name Alternative

SCT-800

UNSPSC

12352203

Target

Factor VIII

Type

Inhibitory Antibodies

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/omfiloctocog-alfa.html

Purity

97.10

Solubility

10 mM in DMSO

Smiles

[Omfiloctocogalfa]

Molecular Weight

(165.32 kDa)

References & Citations

[1]Wu R, et al. Efficacy, safety and pharmacokinetics of recombinant human coagulation factor VIII (omfiloctocog alfa) in previously treated Chinese children with severe hemophilia A. Haemophilia. 2022 Nov;28 (6) :e199-e208.|[2]Mazurkiewicz-Pisarek A, et al. The factor VIII protein and its function. Acta Biochim Pol. 2016;63 (1) :11-16.